Sunrest Lifescience Limited (NSE:SUNREST)
India · Delayed Price · Currency is INR 33.90
0.00 (0.00%)
Jun 12, 2026, 12:55 PM IST
Sunrest Lifescience Revenue
In the fiscal year ending March 31, 2026, Sunrest Lifescience had annual revenue of 708.33M INR with 111.99% growth. Sunrest Lifescience had revenue of 368.22M in the half year ending March 31, 2026, with 116.50% growth.
Revenue
708.33M
Revenue Growth
+111.99%
P/S Ratio
0.21
Revenue / Employee
3.37M
Employees
210
Market Cap
145.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 708.33M | 374.20M | 111.99% |
| Mar 31, 2025 | 334.13M | 39.30M | 13.33% |
| Mar 31, 2024 | 294.83M | 48.41M | 19.64% |
| Mar 31, 2023 | 246.42M | -22.46M | -8.35% |
| Mar 31, 2022 | 268.88M | 99.38M | 58.64% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 8.54B |
| Accent Microcell | 3.56B |
| Zenith Drugs | 1.76B |
| Infinium Pharmachem | 1.57B |
| Quest Laboratories | 1.26B |
| Sotac Pharmaceuticals | 1.02B |
| Vilin Bio Med | 422.63M |
| Medicamen Organics | 226.30M |